TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
ERAS

Erasca Inc

Healthcare · Biotechnology

14.50$ +4.1% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Cash Flow

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow ERAS
Line item 2019 2020 2021 2022 2023 2024 2025
-0.11 -1.76 -0.84 -1.06 -0.84 -0.47 -0.34
0.00 0.03 0.01 0.03 0.03 0.02 0.01
0.00 0.04 0.09 0.21 0.22 0.12 0.09
0.00 3.51 0.20 1.25 – – –
0.02 0.18 0.08 0.16 0.01 0.01 -0.01
0.01 2.08 0.20 0.17 0.01 0.10 0.00
-0.22 -3.83 -0.68 -0.73 -0.76 -0.67 0.35
– – 0.01 0.01 0.01 0.00 0.00
0.18 7.54 4.61 1.00 0.01 1.03 0.00
-0.15 1.94 3.10 -0.78 -1.59 -0.11 0.02
-0.12 -3.84 -1.03 -1.23 -0.86 -0.56 -0.34

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?